HomeInsightsEPS

Genomic Valley Biotech Ltd EPS

Genomic Valley Biotech Ltd EPS

stocks purchased

₹ 0.1 Cr

Volume Transacted

(Nov 7, 2024)

stocks purchased

7.2 K

Stocks Traded

(Nov 7, 2024)

Last Updated on: Nov 08, 2024

Image

Genomic Valley Biotech Ltd

NSE: GENOMICVALLEY

EPS

₹ 0.83

Last updated on: Nov 07, 2024

Key Highlights

  • The Earning per Share of Genomic Valley Biotech Ltd is ₹ 0.83 as of 07 Nov 24.
  • The Earning per Share of Genomic Valley Biotech Ltd changed from ₹ 1.5 to ₹ 0.48 over 10 quarters. This represents a CAGR of -36.60% .

Historical Earning per Share of Genomic Valley Biotech Ltd

No data available

* All values are in

Company Fundamentals for Genomic Valley Biotech Ltd

Market Cap

32 Cr

EPS

0.8

P/E Ratio (TTM) *

126.5

P/B Ratio (TTM) *

8.4

Day’s High *

106.85

Day’s Low

105.0

DTE *

0.0

ROE *

6.6

52 Week High

106.85

52 Week Low

21.0

ROCE *

6.6

Market Price Over Time

1M

1Y

3Y

5Y

Monitoring Genomic Valley Biotech Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
07 Nov 2024105
06 Nov 2024106.85
05 Nov 2024104.8
04 Nov 2024102.75
31 Oct 2024100.75
30 Oct 202498.98
29 Oct 202498.98
28 Oct 202499.95
25 Oct 202498.46
24 Oct 202496.53

BlinkX Score for Genomic Valley Biotech Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Genomic Valley Biotech Ltd

Market Value

32

Asset Value

3

11.4 X

Value addition

* All values are in Rupees

Competitive Comparison of EPS

Historical Market Cap of Genomic Valley Biotech Ltd

No data available

* All values are in crore

Historical Revenue of Genomic Valley Biotech Ltd

No data available

* All values are in crore

Historical EBITDA of Genomic Valley Biotech Ltd

No data available

* All values are in crore

Historical Net Profit of Genomic Valley Biotech Ltd

No data available

* All values are in crore

Dividend Payout Over Time

No data available

Genomic Valley Biotech Ltd News Hub

News

Genomic Valley Biotech to discuss results

Genomic Valley Biotech will hold a meeting of the Board of Directors of the Company on 7 O...

Read more

03 Oct 202415:54

News

Genomic Valley Biotech to convene board meeting

Genomic Valley Biotech will hold a meeting of the Board of Directors of the Company on 29 ...

Read more

24 Jul 202410:21

News

Genomic Valley Biotech schedules board meeting

Genomic Valley Biotech will hold a meeting of the Board of Directors of the Company on 9 M...

Read more

04 May 202410:44

News

Genomic Valley Biotech revises board meeting date

Genomic Valley Biotech has revised the meeting of the Board of Directors which was schedul...

Read more

13 Feb 202411:55

News

Genomic Valley Biotech revises board meeting date

Genomic Valley Biotech has revised the meeting of the Board of Directors which was schedul...

Read more

12 Feb 202411:56

News

Genomic Valley Biotech to conduct board meeting

Genomic Valley Biotech will hold a meeting of the Board of Directors of the Company on 10 ...

Read more

05 Feb 202414:17

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for EPS of Genomic Valley Biotech Ltd

What is the EPS of Genomic Valley Biotech Ltd stock?

The Earnings Per Share (EPS) of Genomic Valley Biotech Ltd is 0.83. An EPS is the amount of net income attributed to each share of a common stock.

How is Genomic Valley Biotech Ltd EPS calculated?

The EPS of Genomic Valley Biotech Ltd is calculated by dividing the net income by the number of outstanding shares. The formula is EPS = (Net Income - Dividends on Preferred Stock) / Average Outstanding Shares.

How often does Genomic Valley Biotech Ltd report its EPS?

Genomic Valley Biotech Ltd typically reports its EPS quarterly and annually, in conjunction with its financial statements and earnings reports.

What factors can influence Genomic Valley Biotech Ltd EPS?

Factors that influence the EPS of Genomic Valley Biotech Ltd include revenue changes, cost fluctuations, operational efficiency, tax rates, and one-time gains or losses.

Can Genomic Valley Biotech Ltd EPS growth indicate future performance?

Yes, consistent growth in Genomic Valley Biotech Ltd EPS can suggest strong financial health and effective management, potentially indicating positive future performance.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*